Here we found that decreased AR may accelerate the stress-induced MDD via altering the miRNA-204-5p/BDNF/AKT/MAPK signaling, and targeting this newly identified signaling with small molecules may help in the development of better therapeutic approaches to reduce the development of MDD. The gene discussed is AKT1; the disease is major depressive disorder.